Lancet Rheumatology

Article	Citations
Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease	573
Reigniting the burnt-out health-care workforce	530
Survivorship of revised and multiply revised knee replacements	279
Molecular signature-based decision making in the era of targeted therapies for systemic lupus erythematosus	229
COVID-19 vaccine-induced T-cell responses in patients with rheumatoid arthritis: preferential induction by ChAdOx1	186
From phenotype to pathophysiology—placing rheumatic diseases in an immunological perspective	184
A disseminated gonococcal infection with spinal locations	176
Women in rheumatology in Africa	142
Thrombotic microangiopathy as a presentation of anti-synthetase syndrome	132
Pathways driving tendinopathy and enthesitis: siblings or distant cousins in musculoskeletal medicine?	131
Can contextual factors improve clarity of the results from clinical trials of low back pain?	131
Brachial plexopathy: an unusual manifestation of Takayasu arteritis	119
Research in Brief	110
Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases	108
Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries	104
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?	88
Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study	86
Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial	84
Biological disease-modification in axial spondyloarthritis: insights from MRI	82
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands	79
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial	73
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial	70
Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica due to lumbar disc herniation	69
Early-stage Dupuytren's disease treatment; a promising next step?	68
Interleukin-5 inhibition in eosinophilic granulomatosis with polyangiitis: time for another approach?	62

Juvenile systemic lupus erythematosus presenting as retinal vasculitis	61
Pausing drugs and spacing vaccines: an open question – Authors' reply	59
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study	57
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study	56
Biosimilars and the era of interchangeability	55
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial	55
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis	54
Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosus	53
Composite endpoints for Sjögren's Syndrome	49
Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis	49
Proof-of-concept studies in axial spondyloarthritis: there are no shortcuts	47
Patient-reported outcomes with anifrolumab in patients with systemic lupus erythematosus	45
The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study	45
Outdoor temperatures and Raynaud's phenomenon in patients with systemic sclerosis	44
Reclassifying ANCA-associated vasculitis: a focus on kidney disease	44
Research in Brief	44
Assessing glucocorticoid toxicity: are the measures sensitive enough?	43
First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study	43
Addition of aerobic physical activity to resistance exercise for hip osteoarthritis (PHOENIX): a randomised comparative effectiveness trial	42
Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology–European League A	41
Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis	41
Pain in clinical trials for knee osteoarthritis: estimation of regression to the mean	41
Polyarthritis and swollen hands and feet in an 80-year-old woman	40
Understanding unmet need: Call for guest Podcast editors	40
Clinical trial design: time to accelerate the pace of change?	40
Let's talk about sex in interstitial lung disease	39
First manifestation of adult-onset Still's disease after COVID-19	39
Kanon Jatuworapruk: bringing out the enjoyment in life	39
Research in Brief	39
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study	38
Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study	37
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study	37
Tackling heterogeneity in Sjögren's disease	36
Mental health before and during the pandemic in people with systemic sclerosis	36
Research in Brief	35
Urgent reform needed for homecare medicines services	35
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19	35
ANCA-associated large and small vessel vasculitis with aorto-pulmonary-renal syndrome	35
Constitutional symptoms of severe childhood-onset polyarteritis nodosa	34
Optimal non-opioid analgesic combinations after total hip arthroplasty – Authors' reply	34
Global access to biological disease-modifying drugs	34
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a p	34
Clinical hypnosis and pain management in sharp debridement of skin ulcers in immune-mediated inflammatory diseases	33
Additional SARS-CoV-2 vaccine doses: a little is better than none	33
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies	33
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial	32
COVID-19: is the rush to boost backed by science?	32
Research in Brief	32
Central sensitisation: causes, therapies, and terminology	31
Destructive juvenile idiopathic arthritis: do not overlook rare genetic skeletal disorders	31

Research in Brief	30
Who will respond to type I interferon receptor blockade in SLE?	30
Telemedicine: is the new normal fit for purpose?	29
Better diagnostic tools needed for biopsy-negative giant cell arteritis	29
Digital self-management for back pain in the UK	28
Call for papers: Sex and gender in rheumatology	28
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national co	27
Pneumococcal vaccine in adults with immune-mediated inflammatory diseases	27
Suspending methotrexate for 2 weeks after COVID-19 vaccination	27
Cranial involvement in giant cell arteritis	27
Advancing research and equity through collaboration	25
The 2024 US election—voting for equitable health care	25
Are we ready for home spirometry for systemic sclerosis-associated ILD?	25
Sex differences of brain oscillatory activity and quantitative sensory testing in people with chronic osteoarthritis pain: a cross-sectional study	25
Intra-articular botulinum toxin A injection for painful base-of-thumb osteoarthritis: a double-blind, randomised, controlled, phase 3 trial (RHIBOT)	24
Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal	24
Explanation for substandard of care comparators in rheumatology randomised trial protocols	24
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort	23
Clinician-reported outcome measures in lupus trials: a problem worth solving	23
JIA care under the microscope	23
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study	22
Correction to Lancet Rheumatol 2025; published online Feb 27. https://doi.org/10.1016/S2665-9913(24)00348-5	22
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials	22
COVID-19: angiotensin II in development of lung immunothrombosis and vasculitis mimics – Author's reply	22
Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level	22
Penélope Palominos: rheumatology by sight and touch	21
COP27 Climate Change Conference: urgent action needed for Africa and the world	21
Calcinosis cutis universalis secondary to scleroderma-polymyositis overlap syndrome	21
The impact of COVID-19 on care of early inflammatory arthritis in the UK	21
Polychondritis in a child	21
Arthritis and fertility: time to think about men	20
Reconciling immunotherapy and autoimmunity: not for the faint of heart	20
Jean Liew: from Bronte scholar to social media influencer	20
Deciphering the cytokine fingerprint of macrophage activation syndrome	20
Pain and wellbeing in young people with arthritis	20
Sex-related differences in health-care use in adult patients with inflammatory arthritis in Ontario, Canada: a population-based cohort study	19
Sex and gender impact on achievement of remission in people with rheumatoid arthritis in Switzerland: a cohort study	19
Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study	18
How long do revised and multiply revised hip replacements last? A retrospective observational study of the National Joint Registry	18
Coronary polyarteritis nodosa	18
Beneficial side-effects of colchicine for patients with gout	18
Gout in central Asia: a few things make a big difference	18
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis – Authors' reply	18
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study	18
For SLE activity and glucocorticoids: aim low	18
Role of plasma exchange in ANCA-associated vasculitis – Authors' reply	17
Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study	17
Research in Brief	17
Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses	17
DAVIX: a vascular outcome measure in systemic sclerosis	17
Research in Brief	17
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial	17
Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case–control study	17
Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica due to lumbar disc herniation – Authors' reply	17
Composite endpoints for Sjögren's Syndrome – Authors' reply	16
Socioeconomic deprivation worsens rheumatoid arthritis	16
Rheumatology congresses post COVID-19: we cannot regress	16
Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease	16
Thank you to our peer reviewers in 2021	16
David Liew: where communication meets medicine	16
A role for interleukin-1 receptor antagonism in severe COVID-19?	16
Effectiveness of a fourth mRNA dose among individuals with systemic autoimmune rheumatic diseases during the Omicron era	16
Ustekinumab with or without methotrexate for psoriatic arthritis?	16
Research in Brief	16
Correction to Lancet Rheumatol 2023; 5: e461–73	16
Digital remote monitoring in rheumatology: using health economics to support wider adoption	16
Coronary polyarteritis nodosa in a young adult	15
Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade	15
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study	15
Prize trends in rheumatology: the Gender Award Gap	15
Prevention of psoriatic arthritis: the next frontier	15
Advancing predictive accuracy for shoulder replacement surgery	15
Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities	15
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study	14
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study	14
Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021	14
Time to revisit the therapeutic benefits of exercise for osteoarthritis?	14
Interosseous tendon inflammation in the hands of patients with clinically suspect arthralgia: analysis of MRI data from a prospective cohort study	13
Research in Brief	13
Cardiovascular risk in gout: time for action	13

How should we define disease and outcomes in axial psoriatic arthritis?	13
Diffuse alveolar haemorrhage during pregnancy in systemic lupus erythematosus	13
Titilola (Lola) Falasinnu: looking out for the overlooked	13
Industry involvement in rheumatology consensus-based recommendations: a systematic review	13
Research in Brief	13
Research in Brief	13
The same genotype gives rise to a spectrum of disorders	12
Research in Brief	12
Clinical meaningfulness of a British Isles Lupus Assessment Group-based Composite Lupus Assessment response in terms of patient-reported outcomes in moderate to severe systemic lupus erythematosus: a	12
Palliative care in patients with rheumatic diseases	12
Time to talk to adults with rheumatic diseases about herpes zoster vaccination	12
Correction to Lancet Rheumatol 2022; 4: e177–87	12
Rheumatic cognitive impairment: a new clinical entity?	12
Vasculitis: the promising road ahead	12
Susac syndrome: challenges of interpreting treatment data in a rare disease	12
Correction to Lancet Rheumatol 2022; 4: e853–63	12
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study	11
Michael Barrett: navigating hostile terrain	11
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study	11
Calcium pyrophosphate deposition disease	11
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised contr	11
The influence of safety warnings on the prescribing of JAK inhibitors	11
Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort study	11
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine	11
Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab	11
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series	11
Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis	10
Predictors of pregnancy outcomes in SLE	10
Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences	10
Cellular responses to SARS-CoV-2 vaccination after B-cell depletion: conflicting results from studies – Authors' reply	10
Central sensitisation: causes, therapies, and terminology – Authors' reply	10
Predictors of pregnancy outcomes in SLE	10
Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study	10
Getting better at quantifying the toxicity of glucocorticoids	10
Research in Brief	10
Expanding role of biomarkers in characterising hyperinflammatory syndromes – Authors' reply	10
Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study	10
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial	9
Kimberly Templeton: creative change maker	9
Inclusion of pregnant populations in clinical trials in China: the ethical considerations	9
Research in Brief	9
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort	9
Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study	9
Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis	9
Synovial tissue for personalised medicine in rheumatoid arthritis: hype or hope?	9
Contesting the BACPAP consortium's consensus – Authors' reply	9
Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021	9
Challenges of designing and conducting cohort studies and clinical trials in populations of pregnant people	9
Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study	9
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease	9
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study	9
Correction to Lancet Rheumatol 2021; 3: e789–97	9
Debashish Danda	9
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, obse	9
Promise and challenges of mesenchymal stromal cell therapy in severe SLE	9